STASH, Vol. 13(5) Opioid use among pregnant women in the US

image_pdfimage_print

Prescription opioids like oxycodone and hydrocodone can, at least temporarily, relieve both emotional and physical pain. As a result, some people use opioids that are prescribed to them or that they otherwise obtained, to cope with sadness or anxiety. This kind of nonmedical opioid use is dangerous even in the short-term in part because it can lead to long-term opioid use or even dependence. Nonmedical opioid use during pregnancy can have potentially adverse health effects for both the pregnant woman and unborn child. This week, STASH reviews a study by Katy Kozhimannil and her colleagues that examined the predictors of nonmedical opioid use among pregnant women in the United States (US).

What was the research question?

What factors are associated with nonmedical opioid use among US pregnant women?

What did the researchers do?

Researchers used data from the National Survey of Drug Use and Health (NSDUH) to examine population estimates of substance use in the US. The NSDUH used probability sampling to estimate what a smaller sample of demographic data would look like if it were weighted to represent a nationally representative sample. The sample included 8,721 female respondents who reported currently being pregnant. This data was used to predict and estimate how substance use and mental health characteristics differed between pregnant women who reported nonmedical opioid use and those that reported no nonmedical opioid use during the past year or 30 days.

What did they find?

Kozhimannil and colleagues found that more than 5% of pregnant women reported nonmedical opioid use during the past year, and less than 1% reported it during the past 30 days. Pregnant women who reported nonmedical opioid use in both the past year (Figure 1) and past 30 days (Figure 2) had higher projected rates of other substance use, anxiety, and depression than those who did not report nonmedical opioid use. Women reporting nonmedical opioid use over the past year also tended to be younger, unmarried, poorer, less education, and on government insurance or uninsured.

STASH_PastYear
Figure. Estimated descriptive characteristics of pregnant women by nonmedical opioid use in the past year. Adapted from Kozhimannil et al. (2017). Click image to enlarge.

STASH_PastMonth
Figure. Estimated descriptive characteristics of pregnant women by nonmedical opioid use in the past 30 days. Adapted from Kozhimannil et al. (2017). Click image to enlarge.

Why do these findings matter?

Access to affordable, quality health care should be available to everyone, particularly pregnant women; however, that is unfortunately not the case in the US. The current study’s results reflect the complicated reality of co-occurring mental health and substance use issues among pregnant women who have a history of nonmedical opioid use. These findings inform public health policy and treatment interventions that should be equipped to identify and address the full spectrum of problems pregnant women might be experiencing. 

Every study has limitations. What about this one?

This study did not track substance use behavior and mental health over time. The researchers gathered data from 2005-2014 but were unable to look at how the sample changed longitudinally, which could have provided additional insights. Also, substance use may have been under-reported by pregnant women due to social desirability bias.

For more information:

Our Addiction Resources page has free, anonymous resources for people concerned about substance use or other expressions of addiction.

— Alec Conte

What do you think? Please use the comment link below to provide feedback on this article.


Leave a Reply

Your email address will not be published. Required fields are marked *